Provenance du réseau au premier degré de Mark W. Womack
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mark W. Womack via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
RoosterBio, Inc.
 RoosterBio, Inc. BiotechnologyHealth Technology RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD. | Biotechnology | Chief Executive Officer | |
| JSR CORPORATION | Chemicals: Specialty | Chief Executive Officer | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
| University of Cambridge | College/University | Doctorate Degree | |
| George Fox University | College/University | Graduate Degree | |
| Georgia State University | College/University | Doctorate Degree | |
| Marylhurst University | College/University | Masters Business Admin | |
| Max-Planck-Institute for Molecular Genetics | College/University | Corporate Officer/Principal | |
JSR Micro, Inc.
 JSR Micro, Inc. Chemicals: SpecialtyProcess Industries JSR Micro, Inc. is a private company that specializes in materials innovation. It is based in Sunnyvale, CA. JSR Micro is ultimately controlled by the Government of Japan. The company was founded in 1990. | Chemicals: Specialty | President | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal | |
| Parenteral Drug Association | Corporate Officer/Principal | ||
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Chief Operating Officer | |
Venturelab AG
 Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Investment Managers | Corporate Officer/Principal | |
| JSR North America Holdings, Inc. | President | ||
Treadwell Therapeutics, Inc.
 Treadwell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Treadwell Therapeutics, Inc. operates as a clinical-stage oncology firm. It develops small molecules designed to leverage world-class, innovative science in cancer biology and immune-oncology with pan-cancer potential, including hematological malignancies from the TIO Discovery development engine. The company was founded by Tak Wah Mak and Mark R. Bray in July 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Operating Officer |
Statistiques
Internationale
| Etats-Unis | 13 |
| Suisse | 3 |
| Allemagne | 3 |
| Japon | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 8 |
| Consumer Services | 7 |
| Process Industries | 3 |
| Commercial Services | 2 |
| Finance | 2 |
Opérationnelle
| Corporate Officer/Principal | 11 |
| Director/Board Member | 9 |
| Chief Executive Officer | 5 |
| President | 5 |
| Chief Operating Officer | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Mark W. Womack
- Connexions Sociétés
